4,8-Dimethoxy-1-vinyl-9H-β-carboline

Modify Date: 2024-01-08 16:40:20

4,8-Dimethoxy-1-vinyl-9H-β-carboline Structure
4,8-Dimethoxy-1-vinyl-9H-β-carboline structure
Common Name 4,8-Dimethoxy-1-vinyl-9H-β-carboline
CAS Number 65236-62-6 Molecular Weight 254.284
Density 1.3±0.1 g/cm3 Boiling Point 491.8±40.0 °C at 760 mmHg
Molecular Formula C15H14N2O2 Melting Point N/A
MSDS N/A Flash Point 174.9±17.6 °C

 Use of 4,8-Dimethoxy-1-vinyl-9H-β-carboline


Dehydrocrenatidine, a natural alkaloid, is a specific JAK inhibitor. Dehydrocrenatidine inhibits voltage-gated sodium channels and ameliorates mechanic allodia in a rat model of neuropathic pain[1][2].

 Names

Name 1-ethenyl-4,8-dimethoxy-9H-pyrido[3,4-b]indole
Synonym More Synonyms

 4,8-Dimethoxy-1-vinyl-9H-β-carboline Biological Activity

Description Dehydrocrenatidine, a natural alkaloid, is a specific JAK inhibitor. Dehydrocrenatidine inhibits voltage-gated sodium channels and ameliorates mechanic allodia in a rat model of neuropathic pain[1][2].
Related Catalog
In Vitro Dehydrocrenatidine inhibits JAK-STAT3 dependent DU145 and MDA-MB-468 cell survival and induces cell apoptosis. Dehydrocrenatidine inhibits JAKs-JH1 domain over-expression induced STAT3 and STAT1 phosphorylations[1]. Dehydrocrenatidine diminishes IL-6, IFNα and IFNγ stimulated STAT3 phosphorylation as well as constitutive STAT3 phosphorylation[1]. DHCT suppresses both tetrodotoxin-resistant (TTX-R) and sensitive (TTX-S) voltage-gated sodium channel (VGSC) currents with IC50 values of 12.36 µM and 4.87 µM, respectively[2].
In Vivo Dehydrocrenatidine inhibits JAK-STAT3 dependent DU145 and MDA-MB-468 cell survival and induces cell apoptosis. Dehydrocrenatidine inhibits JAKs-JH1 domain over-expression induced STAT3 and STAT1 phosphorylations[1]. Dehydrocrenatidine diminishes IL-6, IFNα and IFNγ stimulated STAT3 phosphorylation as well as constitutive STAT3 phosphorylation[1]. DHCT suppresses both tetrodotoxin-resistant (TTX-R) and sensitive (TTX-S) voltage-gated sodium channel (VGSC) currents with IC50 values of 12.36 µM and 4.87 µM, respectively[2].
References

[1]. Jing Zhang, et al. Dehydrocrenatidine is a novel janus kinase inhibitor. Mol Pharmacol. 2015 Apr;87(4):572-81.

[2]. Fang Zhao, et al. Dehydrocrenatidine Inhibits Voltage-Gated Sodium Channels and Ameliorates Mechanic Allodia in a Rat Model of Neuropathic Pain. Toxins (Basel). 2019 Apr 18;11(4):229.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 491.8±40.0 °C at 760 mmHg
Molecular Formula C15H14N2O2
Molecular Weight 254.284
Flash Point 174.9±17.6 °C
Exact Mass 254.105530
PSA 47.14000
LogP 3.70
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.703

 Safety Information

Hazard Codes Xi

 Precursor & DownStream

Precursor  2

DownStream  0

 Synonyms

9H-Pyrido[3,4-b]indole, 1-ethenyl-4,8-dimethoxy-
4,8-Dimethoxy-1-vinyl-9H-β-carboline
8-O-methylpicrasidine I
1-ethenyl-4,8-dimethoxy-9H-β-carboline
Dehydrocrenatidin
Top Suppliers:I want be here




Get all suppliers and price by the below link:

4,8-Dimethoxy-1-vinyl-9H-β-carboline suppliers

4,8-Dimethoxy-1-vinyl-9H-β-carboline price